Related Experiment Video

Updated: Jun 13, 2026

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

Heterophilic antibody interference in a chemiluminescent immunometric erythropoietin assay

Laura Spruill, Mary A Constantin, Dorinda M Andrews

    Clinica Chimica Acta; International Journal of Clinical Chemistry
    |April 27, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Electrochemiluminescence Assays for Human Islet Autoantibodies09:15

    Electrochemiluminescence Assays for Human Islet Autoantibodies

    Published on: March 23, 2018

    Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method09:32

    Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

    Published on: September 10, 2017

    Related Concept Videos

    Enzyme-Linked Immunosorbent Assay01:33

    Enzyme-Linked Immunosorbent Assay

    In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
    There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.